← Back to Search

Virtual Yoga for Insomnia in Cancer Survivors

N/A
Waitlist Available
Led By Karen Mustian, PhD, MPH
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Cancer Survivors must score ≥4 on a 0-10 sleep screening scale
Cancer Survivors must have a confirmed diagnosis of cancer
Must not have
Cancer Survivors must not have a confirmed diagnosis of sleep apnea or restless leg syndrome
Cancer Survivors must not have distant metastases
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 5
Awards & highlights
No Placebo-Only Group

Summary

This trial is examining whether a four-week yoga intervention delivered virtually is effective in improving insomnia and sleep quality in cancer survivors.

Who is the study for?
This trial is for cancer survivors who've finished their surgery, chemo, or radiation between 2 months and 10 years ago. They must have trouble sleeping, be over 18, speak English, and can use the internet with a device. They shouldn't have sleep apnea or restless leg syndrome, be doing yoga already or plan to start it outside of the study.
What is being tested?
The study tests if virtual YOCAS©® yoga helps improve sleep in cancer survivors compared to standard care. Participants are randomly placed into two groups: one does four weeks of online yoga sessions; the other continues regular care without yoga.
What are the potential side effects?
Yoga is generally safe but may include risks like muscle strains or falls for some individuals. Since this is not a drug trial, side effects are minimal compared to medicinal interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I often have trouble sleeping.
Select...
I have a confirmed cancer diagnosis.
Select...
I can read and understand English.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am a cancer survivor without sleep apnea or restless leg syndrome.
Select...
My cancer has not spread to distant parts of my body.
Select...
I am a cancer survivor not on treatment, except for hormone or biologic therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 5
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 5 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Malignant Neoplasms
Secondary study objectives
Malignant Neoplasms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: YOCASExperimental Treatment1 Intervention
Cancer survivors receive 8 virtual yoga sessions (75 minutes/session, 2 times a week for 4 weeks) delivered via an electronic platform (e.g., Zoom)
Group II: Standard CareActive Control1 Intervention
Cancer survivors receive their standard care

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
867 Previous Clinical Trials
548,840 Total Patients Enrolled
7 Trials studying Insomnia
1,846 Patients Enrolled for Insomnia
Bassett Medical CenterOTHER
Karen Mustian, PhD, MPHPrincipal Investigator - University of Rochester
University of Rochester

Media Library

YOCAS©® yoga Clinical Trial Eligibility Overview. Trial Name: NCT04458194 — N/A
Insomnia Research Study Groups: Standard Care, YOCAS
Insomnia Clinical Trial 2023: YOCAS©® yoga Highlights & Side Effects. Trial Name: NCT04458194 — N/A
YOCAS©® yoga 2023 Treatment Timeline for Medical Study. Trial Name: NCT04458194 — N/A
~11 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top